CIRCADIAN THERAPEUTICS LIMITED

Active Oxford

Other human health activities

1 employees website.com
Life sciences and medical technology Other human health activities
C

CIRCADIAN THERAPEUTICS LIMITED

Other human health activities

Founded 18 Jul 2016 Active Oxford, England 1 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 9 Feb 2026 Next due 30 Sept 2027 17 months remaining
Confirmation Submitted 17 Jul 2025 Next due 31 Jul 2026 2 months remaining
Net assets £-3M £47K 2025 year on year
Total assets £70K £96K 2025 year on year
Total Liabilities £3M £49K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

46 Woodstock Road Oxford OX2 6HT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CIRCADIAN THERAPEUTICS LIMITED (10283353), an active life sciences and medical technology company based in Oxford, England. Incorporated 18 Jul 2016. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2017–2025)

Cash in Bank

N/A

Net Assets

-£2.58M

Decreased by £47.18k (-2%)

Total Liabilities

£2.65M

Decreased by £49.08k (-2%)

Turnover

N/A

Employees

1

Decreased by 1 (-50%)

Debt Ratio

3797%

Increased by 2173 (+134%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2016Seed
Investor 2Sept 2016Seed
Investor 3Sept 2016Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 9,675,350 Shares £4.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Nov 2022247£0.247£0.001
11 Jan 202295,913£95.913£0.001
22 Jun 20211,332,827£1k£0.001
26 Feb 20205,435,103£2.90m£0.534
7 Dec 20182,811,260£1.50m£0.534

Officers

Officers

1 active 2 resigned
Status
Michael Frederick SnapeDirectorBritishEngland635 Feb 2019Active

Shareholders

Shareholders (12)

Oxford Science Enterprises Plc
80.1%
Mark Raymond Sampson
4.3%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 12 Sept 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Russell Foster

Ceased 12 Sept 2016

Ceased

Group Structure

Group Structure

CIRCADIAN THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Feb 2026AccountsAnnual accounts made up to 31 Dec 2025
17 Jul 2025Confirmation StatementConfirmation statement made on 17 Jul 2025 with updates
14 Feb 2025AccountsAnnual accounts made up to 31 Dec 2024
15 Jan 2025OfficersAppointment of Ms Wallace Lucy Elizabeth Wallace as director on 15 Jan 2025
7 Nov 2024OfficersTermination of Glenn Robert Leighton as director on 5 Nov 2024
9 Feb 2026 Accounts

Annual accounts made up to 31 Dec 2025

17 Jul 2025 Confirmation Statement

Confirmation statement made on 17 Jul 2025 with updates

14 Feb 2025 Accounts

Annual accounts made up to 31 Dec 2024

15 Jan 2025 Officers

Appointment of Ms Wallace Lucy Elizabeth Wallace as director on 15 Jan 2025

7 Nov 2024 Officers

Termination of Glenn Robert Leighton as director on 5 Nov 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 months ago on 9 Feb 2026

Confirmation statement made on 17 Jul 2025 with updates

9 months ago on 17 Jul 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 14 Feb 2025

Appointment of Ms Wallace Lucy Elizabeth Wallace as director on 15 Jan 2025

1 years ago on 15 Jan 2025

Termination of Glenn Robert Leighton as director on 5 Nov 2024

1 years ago on 7 Nov 2024